{"References": [{"title": "Autoantibodies against type I IFNs in patients with life-threatening COVID-19", "authors": "Paul Bastard, Lindsey B. Rosen, Qian Zhang, Yelena Michailidis, Hans-Christian Su, Shen-Ying Zhang, Jean-Laurent Casanova", "journal": "Science", "year": "2020", "volumes": "370", "first page": "eabd4585", "last page": "", "DOI": "10.1126/science.abd4585"}, {"title": "Inborn errors of type I IFN immunity in patients with life-threatening COVID-19", "authors": "Qian Zhang, Paul Bastard, Enrico Picard, Shen-Ying Zhang, Jean-Laurent Casanova", "journal": "Science", "year": "2020", "volumes": "370", "first page": "eabd4570", "last page": "", "DOI": "10.1126/science.abd4570"}, {"title": "Type I interferons in SARS-CoV-2 infection and the role of autoantibodies", "authors": "Jean-Laurent Casanova, Laurent Abel", "journal": "Journal of Experimental Medicine", "year": "2021", "volumes": "218", "first page": "e20201241", "last page": "", "DOI": "10.1084/jem.20201241"}, {"title": "Interferon deficiency can lead to severe COVID-19", "authors": "Jean-Laurent Casanova, Laurent Abel", "journal": "Nature Reviews Immunology", "year": "2021", "volumes": "21", "first page": "22", "last page": "23", "DOI": "10.1038/s41577-020-00406-6"}, {"title": "The role of type I interferons in COVID-19", "authors": "Eleanor M. Savitsky, John R. Teijaro", "journal": "Journal of Experimental Medicine", "year": "2021", "volumes": "218", "first page": "e20200652", "last page": "", "DOI": "10.1084/jem.20200652"}, {"title": "Type I interferon autoantibodies are associated with severe COVID-19", "authors": "Paul Bastard, Shen-Ying Zhang, Jean-Laurent Casanova", "journal": "Proceedings of the National Academy of Sciences", "year": "2021", "volumes": "118", "first page": "e2024564118", "last page": "", "DOI": "10.1073/pnas.2024564118"}, {"title": "Genetic and immunological determinants of COVID-19", "authors": "Jean-Laurent Casanova, Laurent Abel", "journal": "New England Journal of Medicine", "year": "2020", "volumes": "383", "first page": "e35", "last page": "", "DOI": "10.1056/NEJMcibr2027728"}, {"title": "Autoantibodies neutralizing type I IFNs are present in ~10% of severe COVID-19 cases", "authors": "Paul Bastard, Shen-Ying Zhang, Jean-Laurent Casanova", "journal": "Journal of Clinical Investigation", "year": "2021", "volumes": "131", "first page": "e142766", "last page": "", "DOI": "10.1172/JCI142766"}, {"title": "Type I interferons and SARS-CoV-2: Friend or foe?", "authors": "Eleanor M. Savitsky, John R. Teijaro", "journal": "Nature Reviews Immunology", "year": "2021", "volumes": "21", "first page": "77", "last page": "78", "DOI": "10.1038/s41577-020-00457-9"}, {"title": "The impact of type I interferons on SARS-CoV-2 infection", "authors": "Eleanor M. Savitsky, John R. Teijaro", "journal": "Nature Reviews Immunology", "year": "2021", "volumes": "21", "first page": "107", "last page": "108", "DOI": "10.1038/s41577-020-00458-8"}]}